Patents Assigned to DECIPHERA PHAMACEUTICALS, LLC
  • Publication number: 20120252849
    Abstract: The disclosed compounds are useful in the treatment of mammalian cancers and especially human cancers. Compounds, pharmaceutical compositions, and methods of Formula I are disclosed: or a pharmaceutically acceptable salt, hydrate, solvate, enantiomer, stereoisomer, or tautomer thereof.
    Type: Application
    Filed: May 24, 2012
    Publication date: October 4, 2012
    Applicant: DECIPHERA PHAMACEUTICALS, LLC
    Inventors: Daniel L. Flynn, Michael D. Kaufman